Alveolar accumulation of fibronectin and hyaluronan precedes bleomycin-induced pulmonary fibrosis in the rat

The development of bleomycin-induced pulmonary fibrosis in rats was studied over a period of 30 days after an intratracheal instillation of bleomycin. Fibronectin was visualized in histological sections and quantified in bronchoalveolar lavage fluid (BALF) and related to simultaneous measurements of hyaluronan, collagen and albumin in BALF and/or lung tissue extracts. An increase in BALF fibronectin levels was noted after 3 days and the peak value a sixty fold increase was noted at day 7. Thereafter, the fibronectin levels declined and reached control values on day 21. A pronounced, patchily distributed staining for fibronectin appeared in the injured alveolar tissue parallel to the increased lavage fluid fibronectin levels on days 3-7. A fainter, streakily distributed fibronectin staining remained within the alveolar walls in areas with proliferating fibroblasts on days 14-30. Albumin in BALF increased to a peak level, 20 times control values, after 3 days and then rapidly declined. Thus, the ratio of fibronectin to albumin increased to a peak value of 43 times control values on day 7, indicating that plasma leakage cannot be the only source of the observed increase in lavage fibronectin. Lung tissue hydroxyproline increased between days 7 and 30, whereas extractable hyaluronan in lung tissue and bronchoalveolar lavage fluid peaked on days 3-7 and then gradually declined towards normal values on days 21-30. These data demonstrate that fibronectin accumulates in the alveolar tissue during the early inflammatory phase of the bleomycin-induced lung injury, parallelling hyaluronan accumulation and preceding the development of pulmonary fibrosis.

This article has been cited by other articles:

				A. F. Muro, F. A. Moretti, B. B. Moore, M. Yan, R. G. Atrasz, C. A. Wilke, K. R. Flaherty, F. J. Martinez, J. L. Tsui, D. Sheppard, et al. An Essential Role for Fibronectin Extra Type III Domain A in Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 638 - 645. [Abstract] [Full Text] [PDF]

				F. Gao, J. R. Koenitzer, J. M. Tobolewski, D. Jiang, J. Liang, P. W. Noble, and T. D. Oury Extracellular Superoxide Dismutase Inhibits Inflammation by Preventing Oxidative Fragmentation of Hyaluronan J. Biol. Chem., March 7, 2008; 283(10): 6058 - 6066. [Abstract] [Full Text] [PDF]

				A. Zaman, Z. Cui, J. P. Foley, H. Zhao, P. C. Grimm, H. M. DeLisser, and R. C. Savani Expression and Role of the Hyaluronan Receptor RHAMM in Inflammation after Bleomycin Injury Am. J. Respir. Cell Mol. Biol., November 1, 2005; 33(5): 447 - 454. [Abstract] [Full Text] [PDF]

				W A Dik, R J McAnulty, M A Versnel, B A E Naber, L J I Zimmermann, G J Laurent, and S E Mutsaers Short course dexamethasone treatment following injury inhibits bleomycin induced fibrosis in rats Thorax, September 1, 2003; 58(9): 765 - 771. [Abstract] [Full Text] [PDF]

				N.J. Vanacker, E. Palmans, R.A. Pauwels, and J.C. Kips Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats Eur. Respir. J., October 1, 2002; 20(4): 873 - 879. [Abstract] [Full Text] [PDF]

				R. Koslowski, U. Pfeil, H. Fehrenbach, M. Kasper, E. Skutelsky, and K-W. Wenzel Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat Eur. Respir. J., August 1, 2001; 18(2): 347 - 356. [Abstract] [Full Text] [PDF]

				R. C. Savani, G. Hou, P. Liu, C. Wang, E. Simons, P. C. Grimm, R. Stern, A. H. Greenberg, H. M. DeLisser, and N. Khalil A Role for Hyaluronan in Macrophage Accumulation and Collagen Deposition after Bleomycin-Induced Lung Injury Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 475 - 484. [Abstract] [Full Text]